Industry News
PET/CT bests gold standard bone marrow biopsy for diagnosis and prognosis of lymphoma patients
Aug 05, 2013
A more precise method for determining bone marrow involvement in patients with diffuse large B-cell lymphoma (DLBCL) - a key factor in tailoring patient management plans - has been identified by researchers in a study published in the August issue of The Journal of Nuclear Medicine... Read More
Researchers map a new metabolic pathway that controls mTORC1 activation which is involved in cell growth
Aug 05, 2013
Deciphering the body's complex molecular pathways that lead to disease when they malfunction is highly challenging. Researchers at Sanford-Burnham Medical Research Institute now have a more complete picture of one particular pathway that can lead to cancer and diabetes... Read More
Blocking sugar intake may reduce cancer risk or progression in obese and diabetic people
Aug 05, 2013
Blocking dietary sugar and its activity in tumor cells may reduce cancer risk and progression, according to researchers from the Icahn School of Medicine... Read More
Targeted therapy identified for protein that protects and nourishes cancer - inhibitor found that blocks Skp2
Aug 05, 2013
Scientists at The University of Texas MD Anderson who identified a protein's dual role in cancer promotion have discovered a way to shut it down, opening a potential new avenue for cancer treatment... Read More
Modeling of congenital amegakaryocytic thrombocytopenia using iPS cell technology
Aug 05, 2013
A research group led by researcher Shinji Hirata and Professor Koji Eto at CiRA has conducted a study in which iPS cells generated from a patient with congenital amegakaryocytic thrombocytopenia (CAMT) were induced to differentiate into blood cells in vitro and then used to undertake a detailed study of the differences between these and cells from healthy subjects... Read More
New treatment strategy for breast cancer spread to brain
Aug 05, 2013
A combination of two new therapies already in clinical trials for the treatment of primary malignant brain tumors may also be effective in the treatment of breast cancer that has spread to the brain, according to US researchers. The team, from the University of California Los Angeles, demonstrated their new approach, which combines immunotherapy with gene therapy, in mice... Read More
Novel drug shuts down master protein key to lymphoma
Aug 05, 2013
Researchers have discovered how an experimental drug is capable of completely eradicating human lymphoma in mice after just five doses... Read More
Researchers target 'cell sleep' to lower chances of cancer recurrence and make cancer drugs more effective
Aug 05, 2013
An international research team led by University of Pittsburgh Cancer Institute (UPCI) scientists discovered that by preventing cancer cells from entering a state of cellular sleep, cancer drugs are more effective, and there is a lower chance of cancer recurrence... Read More
Catching cancer early - portable diagnostic device may help
Aug 05, 2013
Reaching a clinic in time to receive an early diagnosis for cancer - when the disease is most treatable - is a global problem. And now a team of Chinese researchers proposes a global solution: have a user-friendly diagnostic device travel to the patient, anywhere in the world. As described in the journal Biomicrofluidics, which is produced by AIP Publishing, a team led by Gang Li, Ph.D... Read More
A roadblock to personalized cancer care? Tumor biomarker tests can help
Aug 05, 2013
There's a major roadblock to creating personalized cancer care. Doctors need a way to target treatments to patients most likely to benefit and avoid treating those who will not. Tumor biomarker tests can help do this. The problem, according to a new commentary paper, is that, unlike drugs or other therapies, cancer biomarker tests are undervalued by doctors and patients... Read More
Previous Page Next Page